Martek Signs Two New Infant Formula Licensees

Martek Signs Two New Infant Formula Licensees Company announces that that infant formula companies Pasteur Milk Co., Ltd. and Semper AB have signed license agreements for use of Martek's docosahexaenoic acid and arachidonic acid in infant formula. Pasteur's license covers South Korea and Semper's license includes Finland, Sweden, Latvia and Lithuania.
Home Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava Modern Science Confirms Ancient Wisdom! Modern Science Confirms Ancient Wisdom! "Natural" or "Plant-Derived" Labeling Can Mislead CDN: Natural Health Products Report - Update NPI Editorial: Are we using Best Practices? AHPA Update: Kava Information from the AHPA Executive Committee European Commission Proposes Registration Scheme for Herbal Medicine to Avoid Need for Testing Statement on Kava in New Zealand BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning AMS Health Sciences, Inc. Announces Appointment of New President Company announces the appointment of Steven G. Kochen, previously general manager of D&F Industries, manufacturer of Herbalife International's nutritional products worldwide, as the Company president. Forbes Medi-Tech Announces Second Quarter Results Company reports revenues of $6.73 million for the quarter, compared to $3.18 million for the previous year's quarter, with a net loss of $3.2 million ($0.09 per share), compared to a net loss of $2.4 million ($0.08 per share) prior year. Forbes Medi-Tech Announces Second Quarter Results Company reports revenues of $6.73 million for the quarter, compared to $3.18 million for the previous year's quarter, with a net loss of $3.2 million ($0.09 per share), compared to a net loss of $2.4 million ($0.08 per share) prior year. Puresource Acquires Assets of Aliments Inari Inc. /Inari Foods Inc. and Produits Biologiques Himex Inc. /Himex Organic Products Inc. Puresource Inc. has purchased the operating assets of Aliments Inari Inc. /Inari Foods Inc. and Produits Biologiques Himex Inc. /Himex Organic Products Inc. in Montreal, QC. Puresource Acquires Assets of Aliments Inari Inc. /Inari Foods Inc. and Produits Biologiques Himex Inc. /Himex Organic Products Inc. Puresource Inc. has purchased the operating assets of Aliments Inari Inc. /Inari Foods Inc. and Produits Biologiques Himex Inc. /Himex Organic Products Inc. in Montreal, QC. Natural Health Trends Corp. Announces Second Quarter and Six Months 2005 Results Company reports net sales of approximately $49.9 million compared to $17.7 million for the same quarter prior year, led by $32.0 million net sales in Hong Kong in the three months. Company records a net loss of approximately $2.2 million, ($0.32 per fully diluted share) versus a net loss of $6.7 million, ($1.24 per fully diluted share) prior year. Natural Health Trends Corp. Announces Second Quarter and Six Months 2005 Results Company reports net sales of approximately $49.9 million compared to $17.7 million for the same quarter prior year, led by $32.0 million net sales in Hong Kong in the three months. Company records a net loss of approximately $2.2 million, ($0.32 per fully diluted share) versus a net loss of $6.7 million, ($1.24 per fully diluted share) prior year. Cyanotech Corporation Reports First Quarter Fiscal 2006 Financial Results Company reports net sales of $3,029,000 compared to $2,707,000 for the same quarter prior year, with growss profit of $1,025,000, an increase of 16% from gross profit of $887,000 for the same period last year. Net income was $153,000, ($0.01 per diluted share), an increase from $113,000, ($0.01 per diluted share), for the comparable quarter of the prior fiscal year. Cyanotech Corporation Reports First Quarter Fiscal 2006 Financial Results Company reports net sales of $3,029,000 compared to $2,707,000 for the same quarter prior year, with growss profit of $1,025,000, an increase of 16% from gross profit of $887,000 for the same period last year. Net income was $153,000, ($0.01 per diluted share), an increase from $113,000, ($0.01 per diluted share), for the comparable quarter of the prior fiscal year. EuroPharma® Forms Joint Venture with VitaPlant, Highly Respected Swiss Research Institute EuroPharma’s president Terry Lemerond has entered into a joint venture with VitaPlant, the Swiss research institute for phytopharmaceutical products, to bring products researched by VitaPlant and develop partnerships with US marketing companies to introduce the products in the US. EuroPharma® Forms Joint Venture with VitaPlant, Highly Respected Swiss Research Institute EuroPharma’s president Terry Lemerond has entered into a joint venture with VitaPlant, the Swiss research institute for phytopharmaceutical products, to bring products researched by VitaPlant and develop partnerships with US marketing companies to introduce the products in the US. EuroPharma® Forms Joint Venture with VitaPlant, Highly Respected Swiss Research Institute EuroPharma’s president Terry Lemerond has entered into a joint venture with VitaPlant, the Swiss research institute for phytopharmaceutical products, to bring products researched by VitaPlant and develop partnerships with US marketing companies to introduce the products in the US. EuroPharma® Forms Joint Venture with VitaPlant, Highly Respected Swiss Research Institute EuroPharma’s president Terry Lemerond has entered into a joint venture with VitaPlant, the Swiss research institute for phytopharmaceutical products, to bring products researched by VitaPlant and develop partnerships with US marketing companies to introduce the products in the US. NutraCea Reports Second Quarter Results Company reports revenue of $299,237 and a net loss reduced to to $1,516,405 compared to a net loss of $2,411,065 for the same quarter of 2004. NutraCea Reports Second Quarter Results Company reports revenue of $299,237 and a net loss reduced to to $1,516,405 compared to a net loss of $2,411,065 for the same quarter of 2004. Frutarom Continues to Achieve Growth Company reports sales of US$ 67.1 million, up 50.5% over prior year, gross profit reached US$ 26.9 million compared with US$ 17.6 million in the same quarter last year. Frutarom Continues to Achieve Growth Company reports sales of US$ 67.1 million, up 50.5% over prior year, gross profit reached US$ 26.9 million compared with US$ 17.6 million in the same quarter last year. Allergy Research Group, Inc. Reports Second Quarter Results Company rports revenue of $3,981,676 for the quarter, compared to $3,832,360 prior year, with net earnings of $324,710 as compared to net earnings of $344,962 for the same period in 2004. Allergy Research Group, Inc. Reports Second Quarter Results Company rports revenue of $3,981,676 for the quarter, compared to $3,832,360 prior year, with net earnings of $324,710 as compared to net earnings of $344,962 for the same period in 2004. Natrol Announces Second Quarter Earnings Company reports sales decrease to $19.6 million for the second quarter of 2005 from $20.7 million prior year, with net income of $291,000 ($0.02 per diluted share), compared to a net loss of $301,000 ($0.02 per share) prior year. Natrol Announces Second Quarter Earnings Company reports sales decrease to $19.6 million for the second quarter of 2005 from $20.7 million prior year, with net income of $291,000 ($0.02 per diluted share), compared to a net loss of $301,000 ($0.02 per share) prior year. St. Paul Pharmaceutical Announces its Expanding Market of Probotics St. Paul Pharmaceutical, a pending merger partner with WENR Corp. announced that it is expanding its marketing of probiotic products to the Canadian, Central and South American markets. St. Paul Pharmaceutical Announces its Expanding Market of Probotics St. Paul Pharmaceutical, a pending merger partner with WENR Corp. announced that it is expanding its marketing of probiotic products to the Canadian, Central and South American markets. PhytoMedical Announces Appointment of New President and CEO Company announces appointment of Mr. Harmel S. Rayat, a current director, to the position of president and chief executive officer PhytoMedical Announces Appointment of New President and CEO Company announces appointment of Mr. Harmel S. Rayat, a current director, to the position of president and chief executive officer PhytoMedical Announces Appointment of New President and CEO Company announces appointment of Mr. Harmel S. Rayat, a current director, to the position of president and chief executive officer PhytoMedical Announces Appointment of New President and CEO Company announces appointment of Mr. Harmel S. Rayat, a current director, to the position of president and chief executive officer Lifeway Foods Inc. Reports Second Quarter Results Company reports revenues of $5.07 million compared to of $4.00 million for the same quarter prior year, and net income of $556,845 ($.07 per share), compared to $432,109 ($.05 per split-adjusted share) in 2004. Lifeway Foods Inc. Reports Second Quarter Results Company reports revenues of $5.07 million compared to of $4.00 million for the same quarter prior year, and net income of $556,845 ($.07 per share), compared to $432,109 ($.05 per split-adjusted share) in 2004. American Oriental Bioengineering Reports 2005 Second Quarter Results Company reports revenue of $11.9 million, compared to $6.0 million for the same period in 2004, and net income of $3.4 million, ($0.08 per basic and diluted share), versus $1.5 million ($0.05 per basic and diluted share), for the comparable period in 2004. American Oriental Bioengineering Reports 2005 Second Quarter Results Company reports revenue of $11.9 million, compared to $6.0 million for the same period in 2004, and net income of $3.4 million, ($0.08 per basic and diluted share), versus $1.5 million ($0.05 per basic and diluted share), for the comparable period in 2004. Heinz Acquires Leading Sauce Brands, Including Lea & Perrins(R), From Groupe Danone for US$820 Million Company has successfully completed its acquisition of the HP Foods Group from Groupe Danone S.A. for GBP 470 million (approximately US$820 million) in cash; transaction includes brands such as Lea & Perrins(R), HP(R) sauces and a perpetual license to market the rapidly growing Amoy(R) Asian sauces brands in Europe. Heinz Acquires Leading Sauce Brands, Including Lea & Perrins(R), From Groupe Danone for US$820 Million Company has successfully completed its acquisition of the HP Foods Group from Groupe Danone S.A. for GBP 470 million (approximately US$820 million) in cash; transaction includes brands such as Lea & Perrins(R), HP(R) sauces and a perpetual license to market the rapidly growing Amoy(R) Asian sauces brands in Europe. Imagenetix Reports 2006 First Quarter Results Company reports revenue of of $2,869,745, compared to $1,186,163 for the prior fiscal year, with net income of $304,011 compared to $290,029 for the same quarter of the prior year. Imagenetix Reports 2006 First Quarter Results Company reports revenue of of $2,869,745, compared to $1,186,163 for the prior fiscal year, with net income of $304,011 compared to $290,029 for the same quarter of the prior year. VitaCube Systems Holdings, Inc. Reports Second Quarter Results Company reports net losses of $1,043,488 compared with net losses of $446,718 for the quarter ended June 30, 2004 with revenues of $222,670 compared with $156,483 prior year. VitaCube Systems Holdings, Inc. Reports Second Quarter Results Company reports net losses of $1,043,488 compared with net losses of $446,718 for the quarter ended June 30, 2004 with revenues of $222,670 compared with $156,483 prior year. Humanetics Corporation Receives Registration Mark for 7-Keto® The registration number for the use of 7-Keto as a trademark is #2,964,802. Humanetics Corporation Receives Registration Mark for 7-Keto® The registration number for the use of 7-Keto as a trademark is #2,964,802. Humanetics Corporation Receives Registration Mark for 7-Keto® The registration number for the use of 7-Keto as a trademark is #2,964,802. Humanetics Corporation Receives Registration Mark for 7-Keto® The registration number for the use of 7-Keto as a trademark is #2,964,802. Humanetics Corporation Receives Registration Mark for 7-Keto® The registration number for the use of 7-Keto as a trademark is #2,964,802. Humanetics Corporation Receives Registration Mark for 7-Keto® The registration number for the use of 7-Keto as a trademark is #2,964,802. Pacifichealth Laboratories, Inc. Announces 2nd Quarter Results Company reports revenues of $2.04 million compared to revenues of $2.2 million for the same period prior year, with a net loss of ($407,350), (($0.04) per share), for the quarter compared to a net loss of ($290,115),(($0.03) per share) for the same period in 2004. Pacifichealth Laboratories, Inc. Announces 2nd Quarter Results Company reports revenues of $2.04 million compared to revenues of $2.2 million for the same period prior year, with a net loss of ($407,350), (($0.04) per share), for the quarter compared to a net loss of ($290,115),(($0.03) per share) for the same period in 2004. PharmaNutrients Awarded CLA Patent Addressing Stress Catabolic Response Company awarded US Patent # 6,927,239 by the US Patent and Trademark Office, entitled “Methods and Compositions for the Attenuation and/or Prevention of Stress Catabolic Response”. PharmaNutrients Awarded CLA Patent Addressing Stress Catabolic Response Company awarded US Patent # 6,927,239 by the US Patent and Trademark Office, entitled “Methods and Compositions for the Attenuation and/or Prevention of Stress Catabolic Response”. PharmaNutrients Awarded CLA Patent Addressing Stress Catabolic Response Company awarded US Patent # 6,927,239 by the US Patent and Trademark Office, entitled “Methods and Compositions for the Attenuation and/or Prevention of Stress Catabolic Response”. PharmaNutrients Awarded CLA Patent Addressing Stress Catabolic Response Company awarded US Patent # 6,927,239 by the US Patent and Trademark Office, entitled “Methods and Compositions for the Attenuation and/or Prevention of Stress Catabolic Response”. Unicity Completes Relocation of Fulfillment Operations to Utah Company has completed the relocation of its North America fulfillment operations from Boca Raton, Florida to the EDS Fulfillment Center in Salt Lake City, Utah. Unicity Completes Relocation of Fulfillment Operations to Utah Company has completed the relocation of its North America fulfillment operations from Boca Raton, Florida to the EDS Fulfillment Center in Salt Lake City, Utah. Unicity Completes Relocation of Fulfillment Operations to Utah Company has completed the relocation of its North America fulfillment operations from Boca Raton, Florida to the EDS Fulfillment Center in Salt Lake City, Utah. Herbalife Appoints Patrick R. Dailey as Senior Vice President, Human Resources Company announces the appointment of Patrick R. Dailey as senior vice president, human resources, responsible for the full Human Resources function for the company. Herbalife Appoints Patrick R. Dailey as Senior Vice President, Human Resources Company announces the appointment of Patrick R. Dailey as senior vice president, human resources, responsible for the full Human Resources function for the company. Herbalife Appoints Patrick R. Dailey as Senior Vice President, Human Resources Company announces the appointment of Patrick R. Dailey as senior vice president, human resources, responsible for the full Human Resources function for the company. Herbalife Appoints Patrick R. Dailey as Senior Vice President, Human Resources Company announces the appointment of Patrick R. Dailey as senior vice president, human resources, responsible for the full Human Resources function for the company. Weider Announces Fiscal 2005 Fourth Quarter & Year-End Results Company reports net sales of $57.0 million for the quarter, compared to $59.1 million prior year, and reported a net loss of $1.8 million, or $(0.07) per share, compared to net income of $1.5 million, or $0.05 per diluted share, for the same period a year ago. Weider Announces Fiscal 2005 Fourth Quarter & Year-End Results Company reports net sales of $57.0 million for the quarter, compared to $59.1 million prior year, and reported a net loss of $1.8 million, or $(0.07) per share, compared to net income of $1.5 million, or $0.05 per diluted share, for the same period a year ago. Galaxy Nutritional Foods Reports First Quarter Operating Results Company reports net sales of approximately $9.9 million, compared with net sales of $11.2 million in the first quarter of the previous year, and a net loss of ($9.1 million), or ($0.49) per share, in the first quarter of FY2006, compared with a net loss of ($0.9 million), or ($0.06) per share, in the prior-year period. Galaxy Nutritional Foods Reports First Quarter Operating Results Company reports net sales of approximately $9.9 million, compared with net sales of $11.2 million in the first quarter of the previous year, and a net loss of ($9.1 million), or ($0.49) per share, in the first quarter of FY2006, compared with a net loss of ($0.9 million), or ($0.06) per share, in the prior-year period. Hain Celestial Announces Definitive Agreement to Acquire Spectrum Organic Products Company announces the signing of a definitive agreement and plan of merger with Spectrum Organic Products, Inc. for approximately $0.705 per share, adjusted to reflect Spectrum's estimate of their expenses and the price adjustment provisions of the agreement, to Spectrum shareholders consisting of approximately 50% in Hain Celestial common shares and 50% in cash. The deal is expected to close in November. Hain Celestial Announces Definitive Agreement to Acquire Spectrum Organic Products Company announces the signing of a definitive agreement and plan of merger with Spectrum Organic Products, Inc. for approximately $0.705 per share, adjusted to reflect Spectrum's estimate of their expenses and the price adjustment provisions of the agreement, to Spectrum shareholders consisting of approximately 50% in Hain Celestial common shares and 50% in cash. The deal is expected to close in November. Hain Celestial Announces Definitive Agreement to Acquire Spectrum Organic Products Company announces the signing of a definitive agreement and plan of merger with Spectrum Organic Products, Inc. for approximately $0.705 per share, adjusted to reflect Spectrum's estimate of their expenses and the price adjustment provisions of the agreement, to Spectrum shareholders consisting of approximately 50% in Hain Celestial common shares and 50% in cash. The deal is expected to close in November. Biogaia Issues Interim Report Company reports 6 month sales of SEK 28.2 million ($3.7 million USD), compared to SEK 20.8 million for the same period prior year, with operating profit of SEK –2.7 million, versus SEK -8.7 million prior year. Biogaia Issues Interim Report Company reports 6 month sales of SEK 28.2 million ($3.7 million USD), compared to SEK 20.8 million for the same period prior year, with operating profit of SEK –2.7 million, versus SEK -8.7 million prior year. The Carlyle Group Agrees to Acquire Shionogi Qualicaps Group from Shionogi Company has agreed to acquire from Shionogi & Co., Ltd. 100 percent of the outstanding shares of four Shionogi subsidiaries—Shionogi Qualicaps Co., Ltd., Shionogi Qualicaps, Inc., Shionogi Qualicaps, S.A., and Shionogi Europe B.V. through a management buyout in a transaction to be completed in October. The Carlyle Group Agrees to Acquire Shionogi Qualicaps Group from Shionogi Company has agreed to acquire from Shionogi & Co., Ltd. 100 percent of the outstanding shares of four Shionogi subsidiaries—Shionogi Qualicaps Co., Ltd., Shionogi Qualicaps, Inc., Shionogi Qualicaps, S.A., and Shionogi Europe B.V. through a management buyout in a transaction to be completed in October. The Carlyle Group Agrees to Acquire Shionogi Qualicaps Group from Shionogi Company has agreed to acquire from Shionogi & Co., Ltd. 100 percent of the outstanding shares of four Shionogi subsidiaries—Shionogi Qualicaps Co., Ltd., Shionogi Qualicaps, Inc., Shionogi Qualicaps, S.A., and Shionogi Europe B.V. through a management buyout in a transaction to be completed in October. Bear Growth Capital Announces Partnership With New Chapter Bear Growth Capital Partners has announced a growth equity investment in New Chapter, Inc. with no financial terms disclosed. Bear Growth Capital Announces Partnership With New Chapter Bear Growth Capital Partners has announced a growth equity investment in New Chapter, Inc. with no financial terms disclosed. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	COLUMBIA, Md., Aug 16, 2005 /PRNewswire-FirstCall via COMTEX/ -- Martek Biosciences Corporation (MATK) announced today that infant formula companies Pasteur Milk Co., Ltd. and Semper AB have signed license agreements for use of Martek's docosahexaenoic acid (DHA) and arachidonic acid (ARA) in infant formula. Pasteur's license covers South Korea and Semper's license includes Finland, Sweden, Latvia and Lithuania. Martek manufactures nutritional oils that contain the long-chain polyunsaturated fatty acids, DHA and ARA, both of which are naturally present in breast milk. Clinical studies have demonstrated benefits for those infants receiving DHA and ARA supplemented formula. Martek's proprietary blend of DHA and ARA is the only source of these nutrients that the FDA has cleared for use in U.S. infant formula, and is currently being sold by the Company's licensees in supplemented formulas in over 60 countries around the world. "Formula companies worldwide continue to recognize the value of adding Martek's DHA and ARA to infant formula," said Henry "Pete" Linsert, Jr., Chairman and CEO of Martek Biosciences Corporation. "These two agreements should soon lead to infant formulas containing Martek's oils in new areas of the world." Martek Biosciences Corporation (MATK) develops, manufactures and sells products from microalgae. The Company's products include: (1) specialty, nutritional oils for infant formula that aid in the development of the eyes and central nervous system in newborns; (2) nutritional supplements and food ingredients that may play a beneficial role in promoting mental and cardiovascular health throughout life; and (3) powerful fluorescent markers for diagnostics, rapid miniaturized screening, and gene and protein detection. For more information, visit http://www.martekbio.com. This press release contains forward-looking statements regarding the commercialization of Martek's products. Such statements involve risks and uncertainties that could cause future actual results to differ due to a variety of risk factors, including without limitation those factors set forth in Martek's filings with the Securities and Exchange Commission.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software